Class IITerminated in FDA datasetRecall initiated Oct 1, 2021

Pharmanex Kids Jungamals, Dietary Supplement 90 Chewable Tablets, white bottle, NSE Products…

Recalling firm: NSE Products, Inc.

Why it was recalled

Pharmanex Jungamals was found to have a missing fish allergen statement on the label due to fish gelatin as a sub-component of the Vitamin E ingredient.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Mar 22, 2022.

Check your package

Compare the exact product and package details with the label you have.

ProductPharmanex Kids Jungamals, Dietary Supplement 90 Chewable Tablets, white bottle, NSE Products Inc., Provo, UT 84601 1-888-PHARMANEX

FDA code information

Batch Code: CS11711; Expiration Date: April 30, 2022

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Pharmanex Kids Jungamals, Dietary Supplement 90 Chewable Tablets, white bottle, NSE Products Inc., Provo, UT 84601 1-888-PHARMANEX

Extracted codes and context

TypeCode / valueContext
batchCS11711Batch Code: CS11711; Expiration Date: April 30, 2022
expirationApril 30, 2022Batch Code: CS11711; Expiration Date: April 30, 2022

Original FDA recall reason

Pharmanex Jungamals was found to have a missing fish allergen statement on the label due to fish gelatin as a sub-component of the Vitamin E ingredient.

Recall details

Recall number
F-0095-2022
Event ID
88804
FDA status
Terminated
Initiated
Oct 1, 2021
Reported
Nov 10, 2021
Classified
Nov 2, 2021
Terminated
Mar 22, 2022
Quantity
470 bottles
Location
Provo, UT, United States
Initiation type
Voluntary: Firm initiated
Notification
E-Mail

Where it was distributed

Distributed directly to consumers nationwide.

FDA source record · F-0095-2022

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.